Respiratory syncytial virus infection in patients with cancer: Still more questions than answers

Clinical Infectious Diseases

Volumn 46, Issue 12, 2008, Pages 1933-1934

  Simon, Arne ^a   Schildgen, Oliver ^a   Panning, Marcus ^a   Bode, Udo ^a   Eis Huebinger, Anna Maria ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MOTAVIZUMAB; PALIVIZUMAB; RIBAVIRIN; ANTIVIRUS AGENT; MONOCLONAL ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE RESPIRATORY FAILURE; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTIFICIAL VENTILATION; ATELECTASIS; CANCER SURVIVAL; FEVER; HUMAN; IMMUNOCOMPROMISED PATIENT; LETTER; MICROBIOLOGY; NEUTROPENIA; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SINGLE DRUG DOSE; VIRUS INFECTION; VIRUS SHEDDING; WHEEZING; ADOLESCENT; BLOOD DISEASE; CHILD; FEMALE; IMMUNOLOGY; INFANT; ISOLATION AND PURIFICATION; MALE; NEOPLASM; NOTE; PRESCHOOL CHILD;

ADOLESCENT; ANTIBODIES, MONOCLONAL; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; INFANT; MALE; NEOPLASMS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; RIBAVIRIN;

EID: 46249124309     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/588559     Document Type: Letter

References (11)

1. Khanna N, Widmer AF, Decker M, et al. Respiratory syncytial virus infection in patients with hematological diseases: single-center study and review of the literature. Clin Infect Dis 2008; 46:402-12.
2. Simon A, Muller A, Khurana K, et al. Nosocomial infection: a risk factor for a complicated course in children with respiratory syncytial virus infection - results from a prospective multicenter German surveillance study. Int J Hyg Environ Health 2007; published online 13 September.
3. Simon A, Khurana K, Wilkesmann A, et al. Nosocomial respiratory syncytial virus infection: impact of prospective surveillance and targeted infection control. Int J Hyg Environ Health 2006; 209:317-24.
4. Hicks KL, Chemaly RF, Kontoyiannis DP. Common community respiratory viruses in patients with cancer: more than just "common colds." Cancer 2003; 97:2576-87.
5. Hirsch HH, Steffen I, Francioli P, Widmer AF. Respiratory syncytial virus infections: measures in immunocompromised patients [in German]. Schweiz Rundsch Med Prax 2006; 95:61-6.
6. Boeckh M, Englund J, Li Y, et al. Randomized controlled multicenter trial of aerosolized ribavirin for respiratory syncytial virus upper respiratory tract infection in hematopoietic cell transplant recipients. Clin Infect Dis 2007; 44:245-9.
7. Raza K, Ismailjee SB, Crespo M, et al. Successful outcome of human metapneumovirus (hMPV) pneumonia in a lung transplant recipient treated with intravenous ribavirin. J Heart Lung Transplant 2007; 26:862-4.
8. Chávez-Bueno S, Mejías A, Merryman RA, Ahmad N, Jafri HS, Ramilo O. Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients. Pediatr Infect Dis J 2007; 26:1089-93.
9. de Fontbrune FS, Robin M, Porcher R, et al. Palivizumab treatment of respiratory syncytial virus infection after allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 2007; 45:1019-24.
10. Whimbey E, Champlin RE, Englund JA, et al. Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients. Bone Marrow Transplant 1995; 16:393-9.
11. Wu H, Pfarr DS, Johnson S, et al. Development of motavizumab, an ultra-potent antibody for the prevention of respiratory syncytial virus infection in the upper and lower respiratory tract. J Mol Biol 2007; 368:652-6